Open-house drug discount agreements

IKK classic·Dresden, Germany·Deadline Jun 05, 2027 · 283 days left·Open·Supplies

Registrieren zum Speichern Open documents

Structured notice only

Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

50/100

Opportunity Score

Needs reviewLow complexity

SuppliesOpen

Warum diese Bewertung?

Chance

50 / 100

Komplexität

15 / 100

Risikofaktoren

No estimated contract value or framework maximum value disclosed; bidders cannot assess potential revenue.

Only the XML notice was analyzed; full procurement documents (agreement terms, self-declaration forms) have not been re...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Überblick

Moderate opportunity

Wichtige Fakten

Supplies contract
2 lots
Duration until Jul 2027
Supply of pharmaceutical products (Nilotinib and Diclofenac) under non-exclusive discount agreements.
Framework agreements with IKK classic, running from August 1, 2025 to July 31, 2027.

Vollständige Zusammenfassung anzeigen

Open House procedure by IKK classic for non-exclusive pharmaceutical discount agreements (Rabattverträge) under §130a SGB V for two active substances (Nilotinib and Diclofenac). Eligible pharmaceutical companies can join at any time from August 1, 2025, to July 31, 2027, subject to submission deadlines. No estimated values or award criteria provided. Submission via email or postal mail; electronic submission not allowed. Eligibility limited to pharmaceutical entrepreneurs per §4 Abs. 18 AMG.

Risiken

No estimated contract value or framework maximum value disclosed; bidders cannot assess potential revenue.

Only the XML notice was analyzed; full procurement documents (agreement terms, self-declaration forms) have not been re...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Eligibility

Only pharmaceutical entrepreneurs as defined in §4 Abs. 18 AMG are eligible (including consortia of such entrepreneurs).

Administrative

Submission of signed contract, all required declarations and documents via email or postal mail; electronic submission not allowed.
Documents must be submitted by the 5th of a month for contract start on the 1st of the following month (or later date if after the 5th).

Anforderungen können unvollständig sein.

Auftraggeber

Name

IKK classic

Ort

Dresden, DEU

E-Mail

[email protected]

Kennung

993-80175-34

Tätigkeit

Health

Lose (2)

LOT-0001

Nilotinib

Nilotinib, allowed only for administration dispersed in applesauce, ATC Code L01AE03. Framework agreement for supply of pharmaceuticals. Performance in DEU, region DED21.

SuppliesEU fundedElectronic submission

Ort

DED21, Germany

Dauer

Jul 2025 - Jul 2027

Kategorie

Pharmaceutical products

Frist

Deadline Jun 05, 2027

LOT-0002

Diclofenac

Diclofenac retard capsules and tablets, strengths 75 mg (pack sizes 30, N2, N3) and 150 mg (pack sizes 10, N1), ATC Code M01AB05. Framework agreement for supply of pharmaceuticals. Performance in DEU, region DED21.